Advisor Group Holdings, Inc. Acorda Therapeutics Inc Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.3 - $1.67 $25 - $140	-84 Reduced 98.82%	1 $0
Q3 2021 Nov 05, 2021	BUY	$3.36 - $4.79 $3 - $4	1 Added 1.19%	85 $0
Q2 2021 Aug 02, 2021	SELL	$3.61 - $5.23 $906 - $1,312	-251 Reduced 74.93%	84 $0
Q1 2021 May 13, 2021	BUY	$3.8 - $8.04 $1,273 - $2,693	335 New	335 $2,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.